Table 1.
Demographic and clinical characteristics of inflammatory bowel disease patients included in the study
| Diagnosis | CD | UC | Total IBD |
|---|---|---|---|
| Number (%) | 245 (59.8) | 165 (40.2) | 410 (100) |
| Median age (years, range) | 39 (17–79) | 43 (15–83) | 40 (15–83) |
| Gender (females, %) | 137 (55.9) | 70 (42.4) | 207 (50.5) |
| Smoking (yes, %) | 102 (41.6) | 63 (38.2) | 165 (40.2) |
| Median disease duration (years, range) | 13 (0–63) | 10 (0–70) | 11 (0–70) |
| Montreal classification for UC | |||
| Proctitis (E1, %) | 14 (8.6) | ||
| Left sided colitis (E2, %) | 59 (35.6) | ||
| Extensive colitis (E3, %) | 92 (55.8) | ||
| Montreal classification for CD | |||
| Inflammatory (B1, %) | 99 (40.4) | ||
| Stricturing (B2, %) | 92 (37.6) | ||
| Penetrating (B3, %) | 54 (22.0) | ||
| Perianal (p, %) | 57 (23.3) | ||
| Ileum (L1, N, %) | 58 (23.7) | ||
| Colon (L2, N, %) | 49 (20.0) | ||
| Ileocolon (L3, N, %) | 132 (53.9) | ||
| Upper GI (L4, N, %) | 6 (2.4) | ||
| Use of immunomodulators (N, %) | 113 (46.1) | 53 (32.1) | 166 (40.%) |
| Use of biologics (N, %) | 94 (38.4) | 20 (12.1) | 114 (27.8) |
| History of surgery for IBD (N, %) | 149 (60.8) | 46 (27.9) | 195 (47.6) |
CD, Crohn’s disease; IBD, inflammatory bowel disease; UC, ulcerative colitis